Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure-Reference-Cited by-同舟云学术

Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure

Published:2005-09 Issue:3 Volume:150 Page:471-477
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Fitzgerald Robert L.,Cremo Rosemary,Gardetto Nancy,Chiu Albert,Clopton Paul,Bhalla Vikas,Maisel Alan S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Heart disease and stroke statistics—2003 update,2002

2. Economic impact of heart failure in the United States;O'Connell;J Heart Lung Transplant,1994

3. Resource Utilization Among Congestive Heart Failure (REACH) Study. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (R.E.A.C.H.) study;McCullough;J Am Coll Cardiol,2002

4. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure;Abraham;J Card Fail,1998

5. Intravenous nesiritide versus nitroglycerin for the treatment of decompensated congestive heart failure—a randomized controlled trial;JAMA,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natriuretic Peptide Receptors (NPRs) as a Potential Target for the Treatment of Heart Failure;Current Heart Failure Reports;2023-09-15

2. N-Terminal Pro-Bnp (NT-ProBNP) and high sensitive troponin levels in patients with ischemic dilated cardiomyopathy and idiopathic dilated cardiomyopathy;Annals of Clinical Cardiology;2023

3. Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets;Cardiovascular Therapy and Prevention;2021-10-16

4. Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure;Journal of the American College of Cardiology;2020-10

5. A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients;IEEE Access;2020